JAKi and anti-IL-7R antibody had no effects on steady state BCL2L1 expression in mature T-ALL or ETP-ALL cells but did decrease MCL1 expression specifically in Zeb2Tg ETP-ALL cells (Fig. S3C). This evidence concerns the gene BCL2L1 and acute lymphoblastic leukemia.